SQI Diagnostics Inc. | Income Statement

Fiscal year is October-September. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
3.00
119.00
443.00
1,421.00
968.00
1,335
Cost of Goods Sold (COGS) incl. D&A
-
-
-
838.00
682.00
1,337
Gross Income
-
-
-
583.00
286.00
2
SG&A Expense
5,866.00
5,141.00
5,610.00
5,499.00
5,923.00
7,066
EBIT
6,532.00
5,674.00
5,718.00
4,916.00
5,637.00
7,068
Unusual Expense
-
106.00
87.00
-
-
-
Interest Expense
-
-
303.00
483.00
521.00
579
Pretax Income
6,507.00
5,760.00
6,097.00
5,399.00
6,158.00
7,647
Income Tax
300.00
300.00
-
360.00
229.00
210
Consolidated Net Income
6,207.00
5,460.00
6,097.00
5,039.00
5,929.00
7,437
Net Income
6,207.00
5,460.00
6,097.00
5,039.00
5,929.00
7,437
Net Income After Extraordinaries
6,207.00
5,460.00
6,097.00
5,039.00
5,929.00
7,437
Net Income Available to Common
6,207.00
5,460.00
6,097.00
5,039.00
5,929.00
7,437
EPS (Basic)
0.15
0.11
0.11
0.07
0.06
0.06
Basic Shares Outstanding
41,961.00
50,982.00
57,484.00
69,233.00
93,806.00
130,974
EPS (Diluted)
0.15
0.11
0.11
0.07
0.06
0.06
Diluted Shares Outstanding
41,961.00
50,982.00
57,484.00
69,233.00
93,806.00
130,974
EBITDA
5,863.00
5,022.00
5,167.00
4,380.00
5,138.00
6,608
Non-Operating Interest Income
25.00
20.00
11.00
-
-
-

About SQI Diagnostics

View Profile
Address
36 Meteor Drive
Toronto Ontario M9W 1A4
Canada
Employees -
Website http://www.sqidiagnostics.com
Updated 07/08/2019
SQI Diagnostics, Inc. is a life sciences and diagnostics company. It develops multiplexed tests and automated systems for customers who need to measure a variety of biomarkers in blood or other common sample types and commercialize proprietary technologies and products for microarray diagnostics. It offers solutions to pharmaceutical and biotechnology drug development, human diagnostic testing, and animal health diagnostic tests.